After an investigation, Canada’s top health agency considers whether to lower the maximum recommended daily dose of the active ingredient in Tylenol and other painkillers.
Using gene testing to find the right drug for the right person at the right time is medicine's cutting edge. Addiction researchers are identifying promising genetic targets for treatments for alcohol, nicotine, and other drugs.
New data on drug and device company payments to doctors largely excludes nurse practitioners and physician assistants, though they play an ever-larger role in health care. One advanced-practice nurse pleaded guilty last month to taking drug company kickbacks.
Medicare has increased oversight of its prescription drug program but many holes remain, allowing fraud and abuse to proliferate. Questionable practices were found at 1,400 pharmacies, which collectively billed Medicare $2.3 billion in 2014.
Congress wouldn’t allow Medicare to pay for benzodiazepines such as Xanax and Ativan until 2013. Now, the medications are among the most prescribed in its drug program.
Researchers raise alarms about unknown health risks of GE’s Omniscan and Bayer’s Magnevist, drugs injected to get better MRI pictures that contain the heavy metal gadolinium.